These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10973623)

  • 1. Involvement of the 5-HT(2) receptor in hyperthermia induced by p-chloroamphetamine, a serotonin-releasing drug in mice.
    Sugimoto Y; Ohkura M; Inoue K; Yamada J
    Eur J Pharmacol; 2000 Sep; 403(3):225-8. PubMed ID: 10973623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-HT(2) receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice.
    Yamada J; Sugimoto Y
    Eur J Pharmacol; 2001 Sep; 427(3):221-5. PubMed ID: 11567652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
    Yamada J; Sugimoto Y; Yoshikawa T
    Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 5-HT(2) receptor subtypes in depletion of 5-HT induced by p-chloroamphetamine in the mouse frontal cortex.
    Yamada J; Sugimoto Y; Ohkura M; Inoue K; Shinozuka K; Kunitomo M
    Brain Res; 2001 Aug; 911(2):141-5. PubMed ID: 11511381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
    Yamada J; Sugimoto Y; Ohkura M; Inoue K
    Biol Pharm Bull; 2001 Oct; 24(10):1195-7. PubMed ID: 11642332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice.
    Sugimoto Y; Ohkura M; Inoue K; Yamada J
    Eur J Pharmacol; 2001 Nov; 430(2-3):265-8. PubMed ID: 11711040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.
    Gleason SD; Lucaites VL; Shannon HE; Nelson DL; Leander JD
    Behav Pharmacol; 2001 Dec; 12(8):613-20. PubMed ID: 11856898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for 5-HT4 receptor involvement in the enhancement of acetylcholine release by p-chloroamphetamine in rat frontal cortex.
    Yamaguchi T; Suzuki M; Yamamoto M
    Brain Res; 1997 Oct; 772(1-2):95-101. PubMed ID: 9406960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
    Fernández MM; Morán A; Martín ML; San Román L
    Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
    Fletcher PJ; Korth KM; Robinson SR; Baker GB
    Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
    Gleason SD; Shannon HE
    Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC; Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of mechanisms of calcitonin analgesia in mice. Involvement of 5-HT3 receptors.
    Ormazábal MJ; Goicoechea C; Alfaro MJ; Sánchez E; Martín MI
    Brain Res; 1999 Oct; 845(2):130-8. PubMed ID: 10536192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
    Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
    Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor.
    Gresch PJ; Walker PD
    Brain Res Mol Brain Res; 1999 Apr; 67(1):190-3. PubMed ID: 10101247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 5-HT and selective 5-HT receptor agonists and antagonists on rat dorsal vagal preganglionic neurones in vitro.
    Albert AP; Spyer KM; Brooks PA
    Br J Pharmacol; 1996 Oct; 119(3):519-26. PubMed ID: 8894172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of 5-hydroxytryptamine-induced contraction in the chicken gastrointestinal tract.
    Kitazawa T; Ukai H; Komori S; Taneike T
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):157-68. PubMed ID: 16553644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
    Holohean AM; Hackman JC
    Br J Pharmacol; 2004 Oct; 143(3):351-60. PubMed ID: 15339859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.